• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PXS
Click for more information
0.00% 8.5¢

PHARMAXIS LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
PXSResults of Meeting22/10/09
PXSCEO Presentation to AGM 200921/10/09
PXSChairman's Address to Shareholders 2009 AGM21/10/09
PXSInvestor Presentation - Quarterly Conference Call14/10/09
PXSAppendix 4C - quarterlyPRICE SENSITIVE14/10/09
PXSPharmaxis Quarterly Report to Shareholders - Sept 200914/10/09
PXSQuarterly Investor Conference Call13/10/09
PXSSecond CF Trial Passes Recruitment TargetPRICE SENSITIVE18/09/09
PXSAppendix 3B - Exercise of Employee Options15/09/09
PXSPharmaxis 2009 Statutory Annual Report11/09/09
PXSNotice of General Meeting/Proxy Form11/09/09
PXSPharmaxis 2009 Annual Review11/09/09
PXSPHARMAXIS TO PRESENT AT EUROPEAN RESPIRATORY SOCIETY MEETING11/09/09
PXSProposed Issue of Securities to Non Executive Director04/09/09
PXSAppendix 3B - Exercise of Employee Options14/08/09
PXSPreliminary Final ReportPRICE SENSITIVE14/08/09
PXSExercise of Employee Options04/08/09
PXSExercise of Employee Options24/07/09
PXSAppendix 4C - Quarterly Cash FlowPRICE SENSITIVE22/07/09
PXSInvestor Conference Call Presentation22/07/09
PXSQuarterly Report to Shareholders June 200922/07/09
PXSPharmaxis Investor Conference Call21/07/09
PXSPharmaxis to Voluntarily De-List from Nasdaq13/07/09
PXSAmended Appendix 3Y06/07/09
PXSAppendix 3Y06/07/09
PXSAppendix 3B - Exercise of Employee Options01/07/09
PXSAppendix 3B - Share Purchase Plan30/06/09
PXSPharmaxis Closes Share Purchase Plan30/06/09
PXSProposed Issue of Employee Options23/06/09
PXSAppendix 3B - Annual Issue of Employee Options23/06/09
PXSAmended Phase 3 Additional Results16/06/09
PXSPhase 3 CF Trial Results Presented at European ConferencePRICE SENSITIVE16/06/09
PXSDisclosure Notice Under Section 708A(5)(e)11/06/09
PXSExercise of Employee Options10/06/09
PXSAppendix 3B - Placement04/06/09
PXSPharmaxis Announces Placement of $47 Million and SPPPRICE SENSITIVE04/06/09
PXSTrading HaltPRICE SENSITIVE02/06/09
PXSUS FDA Accepts Aridol New Drug Application for ReviewPRICE SENSITIVE14/05/09
PXSUpdated Investor Presentation07/05/09
PXSPharmaxis Announces Positive Results of Phase 3 CF TrialPRICE SENSITIVE04/05/09
PXSTrading HaltPRICE SENSITIVE04/05/09
PXSAppendix 3B - Employee Options01/05/09
PXSAppendix 4C - quarterlyPRICE SENSITIVE08/04/09
PXSQuarterly Report to Shareholders - March 200908/04/09
PXSInitial Director's Interest Notice07/04/09
PXSDirector Appointment07/04/09
PXSQuarterly Report to Shareholders and InvestorConference Call06/04/09
PXSPharmaxis Announces Milestone in Phase III Trial for CFPRICE SENSITIVE01/04/09
PXSChange in substantial holding27/03/09
PXSPharmaxis Appoints French Distributor for AridolPRICE SENSITIVE11/03/09
PXSAridol New Drug Application Submitted to FDAPRICE SENSITIVE02/03/09
PXSPharmaxis Builds Senior Management Team17/02/09
PXSChange in substantial holding13/02/09
PXSAppendix 3B Employee Options09/02/09
PXSHalf Yearly Report - December 2008PRICE SENSITIVE06/02/09
PXSAppendix 4C - quarterlyPRICE SENSITIVE28/01/09
PXSQuarterly Report to Shareholders December 200828/01/09
PXSQuarterly Report and Investor Conference Call27/01/09
PXSAppendix 3B - Employee Options19/12/08
PXSResults of Meeting
22/10/09
PXSCEO Presentation to AGM 2009
21/10/09
PXSChairman's Address to Shareholders 2009 AGM
21/10/09
PXSInvestor Presentation - Quarterly Conference Call
14/10/09
PXSAppendix 4C - quarterly
14/10/09PRICE SENSITIVE
PXSPharmaxis Quarterly Report to Shareholders - Sept 2009
14/10/09
PXSQuarterly Investor Conference Call
13/10/09
PXSSecond CF Trial Passes Recruitment Target
18/09/09PRICE SENSITIVE
PXSAppendix 3B - Exercise of Employee Options
15/09/09
PXSPharmaxis 2009 Statutory Annual Report
11/09/09
PXSNotice of General Meeting/Proxy Form
11/09/09
PXSPharmaxis 2009 Annual Review
11/09/09
PXSPHARMAXIS TO PRESENT AT EUROPEAN RESPIRATORY SOCIETY MEETING
11/09/09
PXSProposed Issue of Securities to Non Executive Director
04/09/09
PXSAppendix 3B - Exercise of Employee Options
14/08/09
PXSPreliminary Final Report
14/08/09PRICE SENSITIVE
PXSExercise of Employee Options
04/08/09
PXSExercise of Employee Options
24/07/09
PXSAppendix 4C - Quarterly Cash Flow
22/07/09PRICE SENSITIVE
PXSInvestor Conference Call Presentation
22/07/09
PXSQuarterly Report to Shareholders June 2009
22/07/09
PXSPharmaxis Investor Conference Call
21/07/09
PXSPharmaxis to Voluntarily De-List from Nasdaq
13/07/09
PXSAmended Appendix 3Y
06/07/09
PXSAppendix 3Y
06/07/09
PXSAppendix 3B - Exercise of Employee Options
01/07/09
PXSAppendix 3B - Share Purchase Plan
30/06/09
PXSPharmaxis Closes Share Purchase Plan
30/06/09
PXSProposed Issue of Employee Options
23/06/09
PXSAppendix 3B - Annual Issue of Employee Options
23/06/09
PXSAmended Phase 3 Additional Results
16/06/09
PXSPhase 3 CF Trial Results Presented at European Conference
16/06/09PRICE SENSITIVE
PXSDisclosure Notice Under Section 708A(5)(e)
11/06/09
PXSExercise of Employee Options
10/06/09
PXSAppendix 3B - Placement
04/06/09
PXSPharmaxis Announces Placement of $47 Million and SPP
04/06/09PRICE SENSITIVE
PXSTrading Halt
02/06/09PRICE SENSITIVE
PXSUS FDA Accepts Aridol New Drug Application for Review
14/05/09PRICE SENSITIVE
PXSUpdated Investor Presentation
07/05/09
PXSPharmaxis Announces Positive Results of Phase 3 CF Trial
04/05/09PRICE SENSITIVE
PXSTrading Halt
04/05/09PRICE SENSITIVE
PXSAppendix 3B - Employee Options
01/05/09
PXSAppendix 4C - quarterly
08/04/09PRICE SENSITIVE
PXSQuarterly Report to Shareholders - March 2009
08/04/09
PXSInitial Director's Interest Notice
07/04/09
PXSDirector Appointment
07/04/09
PXSQuarterly Report to Shareholders and InvestorConference Call
06/04/09
PXSPharmaxis Announces Milestone in Phase III Trial for CF
01/04/09PRICE SENSITIVE
PXSChange in substantial holding
27/03/09
PXSPharmaxis Appoints French Distributor for Aridol
11/03/09PRICE SENSITIVE
PXSAridol New Drug Application Submitted to FDA
02/03/09PRICE SENSITIVE
PXSPharmaxis Builds Senior Management Team
17/02/09
PXSChange in substantial holding
13/02/09
PXSAppendix 3B Employee Options
09/02/09
PXSHalf Yearly Report - December 2008
06/02/09PRICE SENSITIVE
PXSAppendix 4C - quarterly
28/01/09PRICE SENSITIVE
PXSQuarterly Report to Shareholders December 2008
28/01/09
PXSQuarterly Report and Investor Conference Call
27/01/09
PXSAppendix 3B - Employee Options
19/12/08
refresh Created with Sketch. REFRESH
 

Top Stories

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.